For instance, breast cancer-derived cell lines have been shown to faithfully recapitulate the genomic features of primary tumors, with HER2 gene amplification correlating with trastuzumab sensitivity both in vitro and in patients [10], demonstrating that clinically observed genotype-response correlations are conserved in cancer cell line models. The gene discussed is ERBB2; the disease is breast carcinoma.